Compare OKYO & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OKYO | ZVIA |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 96.4M |
| IPO Year | 2021 | 2021 |
| Metric | OKYO | ZVIA |
|---|---|---|
| Price | $1.59 | $1.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $6.33 | $4.93 |
| AVG Volume (30 Days) | 43.0K | ★ 670.5K |
| Earning Date | 07-18-2025 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $161,259,000.00 |
| Revenue This Year | N/A | $8.30 |
| Revenue Next Year | N/A | $6.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.01 |
| 52 Week Low | $1.44 | $1.11 |
| 52 Week High | $3.35 | $3.66 |
| Indicator | OKYO | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 47.69 | 57.81 |
| Support Level | $1.58 | $1.12 |
| Resistance Level | $1.73 | $1.53 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 32.86 | 69.14 |
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.